Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial
Author:
Funder
Cancer Couch Foundation
European Regional Development Fund
Cancerfonden
Spanish Clinical Research Network
Ministerio de Economía y Competitividad
Vetenskapsrådet
KWF Kankerbestrijding
Instituto de Salud Carlos III
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference26 articles.
1. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial;Pahlman;Ann Surg,1990
2. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years;Sauer;J Clin Oncol,2012
3. Improved survival with preoperative radiotherapy in resectable rectal cancer;Swedish Rectal Cancer Trial;N Engl J Med,1997
4. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer;Kapiteijn;N Engl J Med,2001
5. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial;Sebag-Montefiore;Lancet,2009
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial;Annals of Oncology;2024-10
2. Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal Cancer;JAMA Network Open;2024-09-12
3. Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative review;Cancer Treatment Reviews;2024-09
4. Does the Initial Treatment of the Primary Tumor Impact Prognosis after Recurrence in Locally Advanced Rectal Cancer? Results From A Retrospective Cohort Analysis;2024-07-29
5. A novel high‐risk model identified by epithelial–mesenchymal transition predicts prognosis and radioresistance in rectal cancer;Molecular Carcinogenesis;2024-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3